Jeanne AMIEL and Laurence LEGEAI‑MALLET

Genetics of Developmental Disorders

Presentation

Jeanne AMIEL

Contact

0144495648

Laurence LEGEAI-MALLET

Contact

01 42 75 43 02

The lab merges the previous “Embryology and genetics of malformations” lab and the group of Laurence Legeai-Mallet from the “Molecular and physiopathological bases of osteochondrodysplasia” lab. We combine complementary expertise related to developmental mechanisms, rare diseases and translational studies. Notably, we bring together expertise in gene regulation, rare Mendelian diseases, signaling pathways, cell and developmental biology and therapeutic approaches. Our research is based on animal models and primary cells or iPSCs from patients, and benefits from partnerships with pharmaceutical companies.  
 
Via the Reference Center for Rare Diseases “Anomalies du Développement”, we recruit patients with undiagnosed conditions for research with a special interest in limb and craniofacial anomalies, neurocristopathies and ciliopathies. We develop cellular and animal models to understand the pathophysiology of the disorders, and we have expertise in leveraging such information for the development of pharmaceuticals.

Genetics of developmental Disorders
Goals
  • To identify the genetic mechanisms underlying developmental disorders
  • To develop technologies for generation of zebrafish models of human disease-causing mutations by precise genome editing,
  • To generate animal and cellular models for human skeletal diseases caused by FGF signaling deregulation, for the development of novel therapeutic approaches (several preclinical trials are ongoing),
  • To develop human iPSC-based 2D and 3D models to investigate the cellular and molecular mechanisms governing human brain development, with a particular focus on primary cilia, chromatin regulation, progenitor fate and neuronal differentiation, using advanced imaging and single-cell multi-omics,
  • To dissect the molecular network, including transcriptional and post-transcriptional regulation, governing enteric and peripheral nervous system differentiation and maintenance.
  • To design cell and drug based therapeutic approaches for replacing lost cells or regulating molecular mechanisms in defective cells
Members

GORDON Chris, CRCN - Craniofacial disorders
GUILLOUET Charlotte, Postdoctoral researcher
DJAZIRI Nabila, IE
PELET Anna, IR
GUIMIER Anne, PH
LYONNET Stanislas, PU-PH
AMIEL Jeanne, PU-PH

THOMAS Sophie, CRCN - Ciliopathies and Brain development
BOUTAUD Lucile, PH 
GAYDA Fanny, IE
MONCLER Candice, PhD student
KHAREBAVA Mariami, M2 student

BONDURAND Nadege, DR2 - Neurocristopathies
PINGAULT Veronique, MCU-PH 
CIRILLO Carla, CRCN
HENRY Mathilde, PhD student
DAY lucie, PhD student

DAMBROISE Emilie, CRCN - Bone diseases related to FGF signaling deregulation
LEGEAI-MALLET Laurence, DRCE
MORICE Anne MCU-PH
VILPREUX Charline, IR
LEMOINE Clara, Ingénieur d'études
de la SEIGLIERE Amélie, Ingénieur d'études
KACI Nabil, IE
FAYAD Chantal, PhD student
LESCARRET Jeanne, PhD Student
PONCET Mathilde, Master student
DU Lingxi, PhD student
RICCI Gianluca, PhD student
MAGNAC Théophile, Ingénieur d'études
BRUNET Guillaume, Ingénieur d'études
FIGUEROA GARCIA Adriana, postdoctoral researcher
KOGANE Nicolas, MD PhD student

Scientific Publications